South & Central America Hospital at Home Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The South and Central America Hospital at Home Market size is expected to reach US$ 2,967.1 Million by 2034 from US$ 1,609.6 Million in 2025. The market is estimated to record a CAGR of 7.1% from 2026 to 2034.

Executive Summary and South and Central America Hospital at Home Market Analysis:

The hospital at home market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The Hospital at Home (HaH) model is in its early stages, with limited widespread implementation, though some exploratory and integrated home-based approaches to acute and chronic care are underway. In Brazil, programs such as Programa Maior Cuidado incorporate elements similar to HaH, offering community-based interventions for older adults that include home-based primary and acute care to avert hospitalizations and support aging populations. These initiatives share features with high-income country models, emphasizing home-based monitoring and multidisciplinary support.

Adoption is constrained by health system structures, infrastructure challenges, and focus on primary care expansion rather than full acute HaH replication. Examples are often embedded in broader home care or community health strategies-such as in Belo Horizonte-where efforts reduce hospital pressures through integrated services. While specific HaH statistics are limited, these programs show promise in improving access, reducing unnecessary admissions, and enhancing care for vulnerable groups in resource-limited settings. However, full-scale models are not yet common across the region.

South & Central America Hospital at Home Market: Strategic Insights

South and Central America Hospital at Home Market Segmentation Analysis:

• By Component, the South and Central America Hospital at Home Market is segmented into Equipment and Devices and Software and Services. The Software and Services segment dominated the market in 2025.
• By Service Type, the South and Central America Hospital at Home Market is segmented into Acute Care at Home, Chronic Disease Management at Home, Post Acute or Transitional Care, Palliative Care and Hospice Care, and Rehabilitation Services. The Palliative Care and Hospice Care segment dominated the market in 2025.
• By Delivery Mode, the South and Central America Hospital at Home Market is segmented into Remote Monitoring and Telehealth, In-person Home Visits, and Hybrid Models. The Remote Monitoring and Telehealth segment dominated the market in 2025.
• By Patient Demographic, the South and Central America Hospital at Home Market is segmented into Adult Patients and Pediatric Patients. The Adult Patients segment dominated the market in 2025.
• By Indication, the South and Central America Hospital at Home Market is segmented into Cardiovascular Conditions, Respiratory Diseases, Orthopedic and Post-Surgical Recovery, Infectious Diseases, Neurological Rehabilitation, and Others. The Neurological Rehabilitation segment dominated the market in 2025.
• By Care Provider, the South and Central America Hospital at Home Market is segmented into Hospitals and Health Systems, Home Health Agencies, Primary Care or Physician Groups, and Private HaH Providers. The Hospitals and Health Systems segment dominated the market in 2025.

South & Central America Hospital at Home Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Hospital at Home Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

South and Central America Hospital at Home Market Outlook

The Hospital at Home (HaH) model-delivering acute inpatient-level care in patients' homes through remote monitoring, telehealth, in-home visits, and diagnostics-offers substantial opportunities for market expansion in 2026. This approach reduces costs by 20-30%, improves patient satisfaction and outcomes, lowers readmissions, and addresses hospital capacity issues, particularly for conditions such as heart failure, infections, and pneumonia. The Acute Hospital Care at Home (AHCaH) waiver program-launched by CMS in 2020-remains the cornerstone, reimbursing at inpatient Medicare rates and enabling over 400 hospitals across 39 states to participate.

The program's waiver authority had been scheduled to expire on January 30, 2026, following a series of short-term extensions tied to government funding resolutions. However, the House passed the Hospital Inpatient Services Modernization Act (H.R. 4313) in December 2025, extending the program through September 30, 2030, and requiring CMS to conduct a study on quality, costs, and patient demographics compared with traditional inpatient care. The bill has moved to the Senate, where bipartisan support exists, but final passage remains pending amid ongoing appropriations discussions. A long-term extension would provide critical stability, decoupling the program from shutdown risks and encouraging investments in technology, staffing, and logistics for broader adoption.

Additional funding avenues support HaH expansion. The Rural Health Transformation Program allocates US$ 50 billion over five years (US$ 10 billion annually starting in 2026), with states receiving awards ranging from US$147 million to US$281 million in the first year. These funds aim to modernize rural care, including implementing innovative models such as HaH to improve access in underserved areas. The MAHA ELEVATE Model-launching in September 2026-offers US$ 100 million for cooperative agreements testing lifestyle interventions complementary to acute care, potentially integrable with HaH for chronic disease management. Providers should monitor Senate action on H.R. 4313, apply for rural funding through state plans, and prepare evidence-based proposals for MAHA opportunities to scale HaH sustainably while navigating potential Medicaid pressures.

South and Central America Hospital at Home Market Country Insights

By country, the South and Central America Hospital at Home Market is segmented into Brazil, Argentina, and the Rest of South and Central America. Brazil held the largest share in 2025.

In Brazil, the Hospital at Home model is primarily embodied in the Programa Melhor em Casa (PMeC), a nationwide SUS initiative launched in 2011 that delivers specialized domiciliary care to avoid prolonged hospitalizations or provide continuity post-discharge for patients with mobility limitations. As of November 2024, the program operates with over 2,187 multiprofessional teams (EMAD, EMAP) across more than 1,000 municipalities, covering approximately 45% of the population and supported by an annual budget of US$ 170.52 million (R$ 895.5 million). In 2023, it recorded 5.19 million attendances-averaging 432,000 per month-with 68.4% of visits for patients aged 60 and older. It targets chronic-agudized conditions (e.g., decompensated diabetes, heart failure, post-AVC sequelae), infections, rehabilitation, palliative care, and high-complexity needs through regular home visits, intensive rehabilitation, clinical monitoring, and individualized plans involving physicians, nurses, physiotherapists, and nutritionists.

Benefits include 70% lower costs compared to inpatient care, reduced hospital stays, lower infection risks, improved quality of life, and optimized bed availability. Recent updates in 2023-2024 incorporated a 30% funding increase, rehabilitation-focused teams for smaller municipalities, telessaude integration, and alignment with the National Palliative Care Policy. Patient families report enhanced humanization, emotional support, and autonomy, particularly for elderly and chronic cases, although most implementations focus on supportive care rather than full acute inpatient-level substitution.

South and Central America Hospital at Home Market Company Profiles

Some of the key players operating in the market include B Braun SE, Medtronic Plc, Air Liquide, Huma Therapeutics Limited, Doccla, LNA-Santé, Inhealthcare, Spirit Health Group Ltd, RIBERA SALUD, and Capio Sverige AB.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South and Central America Hospital at Home Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise